NCT03160248 - An Investigator-initiated Study of Apremilast to Demonstrate Efficacy Nummular Eczema | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 5, 2017

Primary Completion Date

September 15, 2021

Study Completion Date

September 15, 2021

Conditions

Nummular EczemaEczemaDermatitis EczemaNummular Dermatitis

Interventions

DRUG

Apremilast

This study aims on investigating the efficacy of Apremilast in nummular eczema patients.

DRUG

Placebo Oral Tablet

This study aims on investigating the efficacy of Apremilast in nummular eczema patients - placebo controlled

Trial Locations (1)

Technical University Munich - Department of Dermatology, Munich